BCG vaccination in children

BMJ

Volumn 337, Issue 7681, 2008, Pages 1246-1247

  Von Reyn, C Fordham ^a   Zumla, Allmuddin I ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; CHILDHOOD MORTALITY; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION SITE REACTION; INJECTION SITE SCAR; KELOID; LYMPHADENITIS; MORBIDITY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM MICROTI; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; PRIORITY JOURNAL; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; BCG VACCINE; HUMANS; INFANT; MYCOBACTERIUM BOVIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 57549112350     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2086     Document Type: Editorial

References (12)

1. Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, Mahomed H. Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in young children: randomised trial. BMJ 2008;337:a2052.
2. Von Reyn CF, Vuola J. New vaccines for the prevention of tuberculosis. Clin Infect Dis 2002;35:465-74.
3. Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, et al. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guerin during childhood and entering a tuberculosis booster vaccine trial. J Infect Dis 2007;195:118-23.
4. Brandt L, Cunha JF, Olsen AW, Chilima B, Hirsch P, Appelberg R, et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002;70:672-8.
5. Behr MA, Small PM. Has BCG attenuated to impotence? Nature 1997;389:133-4.
6. Clemens JD, Chuong JJ, Feinstein AR. The BCG controversy: a methodological and statistical reappraisal. JAMA 1983;249:2362-9.
7. Ulstrup JC, Jeansson S, Wiker HG, Harboe M. Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination. Infect Immun 1995;63:672-5.
8. Hesseling AC, Hussey G, Cotton M, von Reyn CF, Graham S, Fine P, et al. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis (in press).
9. Kemp EB, Belshe RB, Hoft DF. Immune responses stimulated by percutaneous and intradermal Bacille Calmette-Guerin. J Infect Dis 1996;174:113-9.
10. Kibel MA, Hussey G, Marco C, van der Wal L. An evaluation of the "Japanese tool" for percutaneous vaccination with BCG in neonates. South Afr Med J 1995;85:988-91.
11. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, et al. High rates of clinical and subclinical tuberculosis among ambulatory HIV-positive subjects in Tanzania. Clin Infect Dis 2005;40:1500-7.
12. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006;118:e1350-9.